Clinical Research Papers:
Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck
Metrics: PDF 1743 views | HTML 2650 views | ?
Christian Jacobi1, Isabelle Ayx1, Kristin Fritsche1, Guido Piontek1, Dieter Hoffmann2, Gregor Weirich3 and Andreas Knopf1
1 Department of Otorhinolaryngology, Technical University Munich, München, Germany
2 Institute of Virology, Technische Universität and Helmholtz Zentrum München, München, Germany
3 Institute of Pathology, Technical University Munich, München, Germany
Christian Jacobi, email:
Keywords: BSCC, basaloid squamous carcinoma, head and neck, survival, HPV
Received: September 08, 2014 Accepted: December 12, 2014 Published: December 18, 2014
Objectives: Basaloid-squamous-carcinomas (BSCC) have been considered as aggressive variants of common squamous-cell-carcinomas (HNSCC). Recent studies demonstrated a different clinical course depending on the tumour site. The aim of the study is to analyze the histopathologic/clinical features of BSCC/HNSCC resolved by the HPV-status.
Methods: We analysed the histopathologic/clinical features of BSCC (n=59) and HNSCC (n=981), subdivided due to the HPV status. Differences were analysed using Chi square, Fisher exact, and student’s t-test. Survival rates were calculated by Kaplan–Meier and log-rank test. Prognostic variables were subsequently evaluated by Cox regression.
Results: Our cohort was congruent with the literature regarding sex, age, metastases, and a predilection in the oropharynx. HNSCC/BSCC did not show a different disease-specific-survival. After UICC matching, univariate analysis revealed a better survival of UICC stage IVa BSCC compared to HNSCC (69% vs. 42%, p=0.022) that was associated with a better response to radio-chemotherapy (p = 0.009). These results referred to the high prevalence of HPV+ (86%) oropharyngeal BSCC. Subgroup analysis demonstrated a better survival of HPV+ oropharyngeal BSCC than HPV- BSCC (p=0.017).
Conclusion: The clinical outcome in BSCC depends on the tumour site and HPV-status. Prospective studies have to evaluate the beneficial application of postoperative radio-chemotherapy in HPV+ BSCC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.